Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Chugai Pharmaceutical Co ( (JP:4519) ) is now available.
Chugai Pharmaceutical will propose a year-end dividend of ¥147 per share for the fiscal year ended December 31, 2025, comprising a regular dividend of ¥72 and a special ¥75 commemorative dividend for its 100th anniversary, bringing the total annual dividend to ¥272 per share, a sharp increase from ¥98 the previous year. The move reflects the company’s ninth consecutive year of growth in core net income and a 13.6% year-on-year rise in Core EPS, resulting in a core dividend payout ratio of 99.3% for 2025 and a five-year average of 54.9%, while management reiterates its medium-term target of a 45% payout ratio and guides to a normalized annual dividend of ¥132 per share for 2026, implying a payout ratio of 44.7% and signaling both strong current performance and a planned step-down from one-off centennial payouts for future shareholder returns.
The most recent analyst rating on (JP:4519) stock is a Buy with a Yen9900.00 price target. To see the full list of analyst forecasts on Chugai Pharmaceutical Co stock, see the JP:4519 Stock Forecast page.
More about Chugai Pharmaceutical Co
Chugai Pharmaceutical Co., Ltd. is a leading Japanese pharmaceutical company listed on the Prime Market of the Tokyo Stock Exchange, specializing in the research, development and commercialization of prescription drugs, with a focus on innovative therapies and a strategy of delivering stable returns to shareholders through a disciplined dividend policy linked to core earnings.
Average Trading Volume: 2,301,476
Technical Sentiment Signal: Buy
Current Market Cap: Yen14209.7B
For detailed information about 4519 stock, go to TipRanks’ Stock Analysis page.